Document:

EXHIBIT
10.3

 

FORM
OF TRANSACTION SUPPORT AGREEMENT

 

This
TRANSACTION SUPPORT AGREEMENT (this “Agreement”) is entered into as of August __, 2022, by and among Minority
Equality Opportunities Acquisition Inc., a Delaware corporation (“MEOA”), and [●], a [●] (the “Stockholder”).
Each of MEOA and the Stockholder are sometimes referred to herein individually as a “Party” and collectively as the
“Parties”. Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to them in the
BCA (as defined below).

 

RECITALS

 

WHEREAS,
[concurrent herewith][on August __, 2022], MEOA, MEOA Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of MEOA
(“Merger Sub”), and Digerati Technologies, Inc., a Nevada corporation (the “Company”), [is entering][entered
into] that certain Business Combination Agreement (as amended, supplemented or otherwise modified from time to time in accordance with
its terms, the “BCA”) pursuant to which, among other things, Merger Sub will merge with and into the Company, with
the Company as the surviving corporation in the merger and, after giving effect to such merger, becoming a wholly-owned Subsidiary of
MEOA, and each Company Share (including the Subject Company Shares (as defined below)) will be converted into the right to receive MEOA
Shares, in each case, on the terms and subject to the conditions set forth in the BCA;

 

WHEREAS,
the Stockholder is the record and beneficial owner of the number and type of Equity Securities of the Company set forth on Schedule
A hereto (together with any other Equity Securities of the Company of which the Stockholder acquires record or beneficial ownership
after the date hereof, and prior to any meeting of the stockholders of the Company described in Section 1(a) below, including, without
limitation, upon exercise of outstanding options and warrants and upon conversion of outstanding convertible indebtedness), (collectively,
the “Subject Company Shares”);

 

WHEREAS,
in consideration for the benefits to be received by the Stockholder under the terms of the BCA and as a material inducement to MEOA
and the other MEOA Parties agreeing to enter into and consummate the transactions contemplated by the BCA, the Stockholder agrees to
enter into this Agreement and to be bound by the agreements, covenants and obligations contained in this Agreement; and

 

WHEREAS,
the Parties acknowledge and agree that MEOA and the other MEOA Parties would not have entered into and agreed to consummate the transactions
contemplated by the BCA without the Stockholder entering into this Agreement and agreeing to be bound by the agreements, covenants and
obligations contained in this Agreement.

 

NOW,
THEREFORE, in consideration of the premises and the mutual promises set forth herein and for other good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged, the Parties, each intending to be legally bound, hereby agree as follows:

 

AGREEMENT

 

1.
Company Stockholder Support and Related Matters.

 

(a)
 At any meeting of the stockholders of the Company prior to the termination of this Agreement,
however called, or at any adjournment thereof, or in any other circumstance in which the vote, consent or other approval of the stockholders
of the Company is sought, the Stockholder shall (a) appear at each such meeting or otherwise cause all of its Subject Company Shares
to be counted as present thereat for purposes of calculating a quorum and (b) vote (or cause to be voted), in person or by proxy, or
execute and deliver, as promptly as reasonably practicable (and in any event within 48 hours) following any request therefor, a written
consent (in such other form and substance as reasonably agreed by MEOA and the Company), or cause such a written consent to be executed
and delivered, covering all of its Subject Company Shares, (i) approving and adopting the Business Combination Agreement and the transactions
contemplated thereby (including the Merger), (ii) against any proposal relating to a Company Acquisition Proposal, and (iii) against
any proposal, action or agreement that would impede, frustrate, prevent or nullify the consummation of the Merger (including those proposals
that would result in a breach in any respect of any covenant, representation, warranty or other obligation or agreement of the Company
under the Business Combination Agreement) or any of the other transactions contemplated by the Business Combination Agreement.

 

    1

     

    

 

(b) Without
limiting any other rights or remedies of MEOA, the Stockholder hereby irrevocably appoints MEOA or any individual designated by MEOA
as the Stockholder’s agent, attorney-in-fact and proxy (with full power of substitution and resubstituting), for and in the name,
place and stead of the Stockholder, to attend on behalf of the Stockholder any meeting of the Company Stockholders with respect to the
matters described in Section 1(a), to include the Subject Company Shares in any computation for purposes of establishing a quorum at
any such meeting of the Company Stockholders, to vote (or cause to be voted) the Subject Company Shares or consent (or withhold consent)
with respect to any of the matters described in Section 1(a) in connection with any meeting of the Company Stockholders or any action
by written consent by the Company Stockholders, in each case, in the event that the Stockholder fails to perform or otherwise comply
with the covenants, agreements or obligations set forth in Section 1(a).

 

(c)
 The proxy granted by the Stockholder pursuant to Section 1(b) is coupled with an interest sufficient
in law to support an irrevocable proxy and is granted in consideration for MEOA entering into the BCA and agreeing to consummate the
transactions contemplated thereby. The proxy granted by the Stockholder pursuant to Section 1(b) is also a durable proxy and shall survive
the bankruptcy, dissolution, death, incapacity or other inability to act by the Stockholder and shall revoke any and all prior proxies
granted by the Stockholder with respect to the Subject Company Shares. The vote or consent of the proxyholder in accordance with Section
1(b) and with respect to the matters in Section 1(a) shall control in the event of any conflict between such vote or consent by the proxyholder
of the Subject Company Shares and a vote or consent by the Stockholder of the Subject Company Shares (or any other Person with the power
to vote the Subject Company Shares) with respect to the matters in Section 1(a). The proxyholder may not exercise the proxy granted pursuant
to Section 1(b) on any matter except those provided in Section 1(a). For the avoidance of doubt, the Stockholder may vote the Subject
Company Shares on all other matters, subject to, for the avoidance of doubt, the other applicable covenants, agreements and obligations
set forth in this Agreement.

 

2.
 Other Covenants and Agreements.

 

(a)
 The Stockholder shall be bound by and subject to (i) Sections 5.3(a) (Confidentiality) and
5.4(a) (Public Announcements) of the BCA to the same extent as such provisions apply to the parties to the BCA, as if the Stockholder
is directly party thereto, and (ii) the first sentence of Section 5.6(a) (Exclusive Dealing) and Section 8.18 (Trust Account Waiver)
of the BCA to the same extent as such provisions apply to the Company, as if the Stockholder is directly party thereto.

 

(b)
 The Stockholder acknowledges and agrees that MEOA and the other MEOA Parties are entering into
the BCA in reliance upon the Stockholder entering into this Agreement and agreeing to be bound by, and perform, or otherwise comply with,
as applicable, the agreements, covenants and obligations contained in this Agreement and but for the Stockholder entering into this Agreement
and agreeing to be bound by, and perform, or otherwise comply with, as applicable, the agreements, covenants and obligations contained
in this Agreement, MEOA and the other MEOA Parties would not have entered into or agreed to consummate the transactions contemplated
by the BCA.

 

(c)
 The Stockholder hereby agrees, in connection with the closing of the Merger, to execute a customary
lock-up agreement with respect to any MEOA Shares received by such Stockholder in the Merger, which, in any event, shall terminate no
later than 180 days from the Closing.

 

3.
 Stockholder Representations and Warranties. The Stockholder represents and warrants
to MEOA as follows:

 

(a)
 If such Stockholder is not an individual, the Stockholder is a corporation, limited liability
company or other applicable business entity duly organized or formed, as applicable, validly existing and in good standing (or the equivalent
thereof, if applicable, in each case, with respect to the jurisdictions that recognize the concept of good standing or any equivalent
thereof) under the Laws of its jurisdiction of formation or organization (as applicable).

 

(b)
 If such Stockholder is not an individual, the Stockholder has the requisite corporate, limited
liability company or other similar power and authority to execute and deliver this Agreement, to perform its covenants, agreements and
obligations hereunder (including, for the avoidance of doubt, those covenants, agreements and obligations hereunder that relate to the
provisions of the BCA), and to consummate the transactions contemplated hereby. The execution and delivery of this Agreement has been
duly authorized by all necessary corporate (or other similar) action on the part of the Stockholder. This Agreement has been duly and
validly executed and delivered by the Stockholder and constitutes a valid, legal and binding agreement of the Stockholder (assuming that
this Agreement is duly authorized, executed and delivered by MEOA), enforceable against the Stockholder in accordance with its terms
(subject to applicable bankruptcy, insolvency, reorganization, moratorium or other Laws affecting generally the enforcement of creditors’
rights and subject to general principles of equity).

 

    2

     

    

 

(c)
 No consent, approval or authorization of, or designation, declaration or filing with, any Governmental
Entity is required on the part of the Stockholder with respect to the Stockholder’s execution, delivery or performance of its covenants,
agreements or obligations under this Agreement (including, for the avoidance of doubt, those covenants, agreements and obligations under
this Agreement that relate to the provisions of the BCA) or the consummation of the transactions contemplated hereby, except for any
consents, approvals, authorizations, designations, declarations, waivers or filings, the absence of which would not adversely affect
the ability of the Stockholder to perform, or otherwise comply with, any of its covenants, agreements or obligations hereunder in any
material respect.

 

(d)
 None of the execution or delivery of this Agreement by the Stockholder, the performance by
the Stockholder of any of its covenants, agreements or obligations under this Agreement (including, for the avoidance of doubt, those
covenants, agreements and obligations under this Agreement that relate to the provisions of the BCA) or the consummation of the transactions
contemplated hereby will, directly or indirectly (with or without due notice or lapse of time or both) (i) result in any breach of any
provision of the Stockholder’s Governing Documents, (ii) result in a violation or breach of, or constitute a default or give rise
to any right of termination, Consent, cancellation, amendment, modification, suspension, revocation or acceleration under, any of the
terms, conditions or provisions of any Contract to which the Stockholder is a party, (iii) violate, or constitute a breach under, any
Order or applicable Law to which the Stockholder or any of its properties or assets are bound or (iv) result in the creation of any Lien
upon the Subject Company Shares, except, in the case of any of clauses (ii) and (iii) above, as would not adversely affect the ability
of the Stockholder to perform, or otherwise comply with, any of its covenants, agreements or obligations hereunder in any material respect.

 

(e)
 The Stockholder is the record owner of the Subject Company Shares and has valid, good and marketable
title to the Subject Company Shares, free and clear of all Liens (other than transfer restrictions under applicable Securities Law).
Except for the Equity Securities of the Company set forth on Schedule A hereto, together with any other Equity Securities of the
Company of which the Stockholder acquires record or beneficial ownership after the date hereof that is either permitted pursuant to,
or acquired in accordance with, Section 5.1(b)(iv) of the BCA, the Stockholder does not own, beneficially or of record, any Equity Securities
of any Group Company. Except as otherwise expressly contemplated by the Company Stockholders Agreement, the Stockholder does not have
the right to acquire any Equity Securities of any Group Company. The Stockholder has the sole right to vote (and provide consent in respect
of, as applicable) the Subject Company Shares and, except for this Agreement and the BCA, the Stockholder is not party to or bound by
(i) any option, warrant, purchase right, or other Contract that would (either alone or in connection with one or more events, developments
or events (including the satisfaction or waiver of any conditions precedent)) require the Stockholder to Transfer (as defined below)
any of the Subject Company Shares or (ii) any voting trust, proxy or other Contract with respect to the voting or Transfer of any of
the Subject Company Shares.

 

(f)
 There is no Proceeding pending or, to the Stockholder’s knowledge, threatened against
the Stockholder that, if adversely decided or resolved, would reasonably be expected to adversely affect the ability of the Stockholder
to perform, or otherwise comply with, any of its covenants, agreements or obligations under this Agreement in any material respect.

 

(g)
 The Stockholder, on his, her or its own behalf and on behalf of his, her or its Representatives,
acknowledges, represents, warrants and agrees that (i) he, she or it has conducted his, her or its own independent review and analysis
of, and, based thereon, has formed an independent judgment concerning, the business, assets, condition, operations and prospects of,
the MEOA Parties and (ii) he, she or it has been furnished with or given access to such documents and information about the MEOA Parties
and their respective businesses and operations as he, she or it and his, her or its Representatives have deemed necessary to enable him,
her or it to make an informed decision with respect to the execution, delivery and performance of this Agreement, the other Ancillary
Documents to which he, she or it is or will be a party and the transactions contemplated hereby and thereby.

 

    3

     

    

  

(h)
 In entering into this Agreement and the other Ancillary Documents to which he, she or it is
or will be a party, the Stockholder has relied solely on his, her or its own investigation and analysis and the representations and warranties
expressly set forth in the Ancillary Documents to which he, she or it is or will be a party and no other representations or warranties
of any MEOA Party (including, for the avoidance of doubt, none of the representations or warranties of any MEOA Party set forth in the
BCA or any other Ancillary Document), any MEOA Non-Party Affiliate or any other Person, either express or implied, and the Stockholder,
on his, her or its own behalf and on behalf of his, her or its Representatives, acknowledges, represents, warrants and agrees that, except
for the representations and warranties expressly set forth in the Ancillary Documents to which he, she or it is or will be a party, none
of the MEOA Parties, any MEOA Non-Party Affiliate or any other Person makes or has made any representation or warranty, either express
or implied, in connection with or related to this Agreement, the Ancillary Documents to which he, she or it is or will be a party or
the transactions contemplated hereby or thereby.

 

4.
 Transfer of Subject Securities. Except as expressly contemplated by the BCA or with
the prior written consent of MEOA (such consent to be given or withheld in its sole discretion), from and after the date hereof until
the termination of this Agreement, the Stockholder agrees not to (a) Transfer any of the Subject Company Shares, (b) enter into (i) any
option, warrant, purchase right, or other Contract that would (either alone or in connection with one or more events or developments
(including the satisfaction or waiver of any conditions precedent)) require the Stockholder to Transfer the Subject Company Shares or
(ii) any voting trust, proxy or other Contract with respect to the voting or Transfer of the Subject Company Shares, or (c) take any
actions in furtherance of any of the matters described in the foregoing clauses (a) or (b). For purposes of this Agreement, “Transfer”
means any, direct or indirect, sale, offer, transfer, assignment, pledge, mortgage, exchange, hypothecation, grant of a security interest
in or disposition or encumbrance of an interest (whether with or without consideration, whether voluntarily or involuntarily or by operation
of law or otherwise), grant of any option to purchase or otherwise dispose of or agreement to dispose of, establishment or increase of
a put equivalent position or liquidation with respect to or decrease of a call equivalent position, entry into any swap or other arrangement,
or public announcement of any intention to effect any of the foregoing.

 

5.
 Termination. This Agreement shall automatically terminate, without any notice or other
action by any Party, and be void ab initio upon the earlier of (a) the Effective Time; and (b) the termination of the BCA in accordance
with its terms. Upon termination of this Agreement as provided in the immediately preceding sentence, none of the Parties shall have
any further obligations or Liabilities under, or with respect to, this Agreement. Notwithstanding the foregoing or anything to the contrary
in this Agreement, the termination of this Agreement pursuant to Section 5(b) shall not affect any Liability on the part of any Party
for a Willful Breach of any covenant or agreement set forth in this Agreement prior to such termination or Fraud.

 

6.
 Fiduciary Duties. Notwithstanding anything in this Agreement to the contrary, (a) the
Stockholder makes no agreement or understanding herein in any capacity other than in such Stockholder’s capacity as a record holder
and beneficial owner of the Subject Company Shares, and, if applicable, not in such Stockholder’s capacity as a director, officer
or employee of the Company or any of the Company’s Subsidiaries and (b) if applicable, nothing herein will be construed to limit
or affect any action or inaction by such Stockholder as a member of the board of directors of any Group Company or as an officer, employee
or fiduciary of any Group Company, in each case, acting in such person’s capacity as a director, officer, employee or fiduciary
of such Group Company.

 

7.
 No Recourse. Except for claims pursuant to the BCA or any other Ancillary Document by
any party(ies) thereto against any other party(ies) thereto, each Party agrees that (a) this Agreement may only be enforced against,
and any action for breach of this Agreement may only be made against, the Parties, and no claims of any nature whatsoever (whether in
tort, contract or otherwise) arising under or relating to this Agreement, the negotiation hereof or its subject matter, or the transactions
contemplated hereby shall be asserted against the Company or any Company Non-Party Affiliate (other than the Stockholder named as a party
hereto, on the terms and subject to the conditions set forth herein) or any MEOA Non-Party Affiliate, and (b) none of the Company, any
Company Non-Party Affiliates (other than the Stockholder named as a party hereto, on the terms and subject to the conditions set forth
herein) or any MEOA Non-Party Affiliate shall have any Liability arising out of or relating to this Agreement, the negotiation hereof
or its subject matter, or the transactions contemplated hereby, including with respect to any claim (whether in tort, contract or otherwise)
for breach of this Agreement or in respect of any written or oral representations made or alleged to be made in connection herewith,
as expressly provided herein, or for any actual or alleged inaccuracies, misstatements or omissions with respect to any information or
materials of any kind furnished in connection with this Agreement, the negotiation hereof or the transactions contemplated hereby.

 

    4

     

    

 

8.
 Notices. All notices, requests, claims, demands and other communications hereunder shall
be in writing and shall be given (and shall be deemed to have been duly given) by delivery in person, by e-mail (having obtained electronic
delivery confirmation thereof (i.e., an electronic record of the sender that the email was sent to the intended recipient thereof without
an “error” or similar message that such email was not received by such intended recipient)), or by registered or certified
mail (postage prepaid, return receipt requested) (upon receipt thereof) to the other Parties as follows:

 

If
to MEOA, to:

 

Minority
Equality Opportunities Acquisition Inc.

100
Executive Court

Waxahachie,
TX 75165

Attention: Shawn D. Rochester

E-mail: srochester@meoaus.com

 

with
a copy (which shall not constitute notice) to:

 

Pryor
Cashman LLP

7
Times Square

New
York, NY 10033

Attention: M. Ali Panjwani, Esq.

E-mail: Ali.Panjwani@pryorcashman.com

 

If
to the Stockholder, to:

 

[        
        ]

[                 ]

[                 ]

Attention:
[        ]

Email:
[          ]

 

with
a copy (which shall not constitute notice) to:

 

Lucosky
Brookman LLP

101 Wood Avenue South, 5th Floor

Woodbridge, NJ 08830

Attention:
Victoria A. Baylin, Esq.

Email:
VBaylin@lucbro.com

 

or
to such other address as the Party to whom notice is given may have previously furnished to the others in writing in the manner set forth
above.

 

9.
 Entire Agreement. This Agreement, the BCA and the documents referred to herein and therein
constitute the entire agreement of the Parties with respect to the subject matter of this Agreement, and supersede all prior agreements
and undertakings, both written and oral, among the Parties with respect to the subject matter of this Agreement, except as otherwise
expressly provided in this Agreement.

 

10.
 Amendments and Waivers; Assignment. Any provision of this Agreement may be amended or
waived if, and only if, such amendment or waiver is in writing and signed by the Stockholder and MEOA. Notwithstanding the foregoing,
no failure or delay by any Party in exercising any right hereunder shall operate as a waiver thereof nor shall any single or partial
exercise thereof preclude any other or further exercise of any other right hereunder. Neither this Agreement nor any of the rights, interests
or obligations hereunder shall be assignable by the Stockholder without MEOA’s prior written consent (to be withheld or given in
its sole discretion).

 

    5

     

    

 

11.
 Fees and Expenses. Except as otherwise expressly set forth in the BCA, all fees and
expenses incurred in connection with this Agreement and the transactions contemplated hereby, including the fees and disbursements of
counsel, financial advisors and accountants, shall be paid by the Party incurring such fees or expenses.

 

12.
 Remedies. Except as otherwise expressly provided herein, any and all remedies provided
herein will be deemed cumulative with and not exclusive of any other remedy conferred hereby, or by law or equity upon such Party, and
the exercise by a Party of any one remedy will not preclude the exercise of any other remedy. The Parties agree that irreparable damage
for which monetary damages, even if available, would not be an adequate remedy, would occur in the event that either Party does not perform
its respective obligations under the provisions of this Agreement in accordance with their specific terms or otherwise breach such provisions.
It is accordingly agreed that each Party shall be entitled to an injunction or injunctions, specific performance and other equitable
relief to prevent breaches of this Agreement and to enforce specifically the terms and provisions of this Agreement, in each case, without
posting a bond or undertaking and without proof of damages and this being in addition to any other remedy to which they are entitled
at law or in equity. Each Party agrees that it will not oppose the granting of an injunction, specific performance and other equitable
relief when expressly available pursuant to the terms of this Agreement on the basis that the other parties have an adequate remedy at
law or an award of specific performance is not an appropriate remedy for any reason at law or equity.

 

13.
 No Third Party Beneficiaries. This Agreement shall be for the sole benefit of the Parties
and their respective successors and permitted assigns and is not intended, nor shall be construed, to give any Person, other than the
Parties and their respective successors and assigns, any legal or equitable right, benefit or remedy of any nature whatsoever by reason
this Agreement. Nothing in this Agreement, expressed or implied, is intended to or shall constitute the Parties, partners or participants
in a joint venture.

 

14.
 Miscellaneous. Sections 8.1 (Non-Survival), 8.5 (Governing Law), 8.7 (Construction;
Interpretation), 8.10 (Severability), 8.11 (Counterparts; Electronic Signatures), 8.15 (Waiver of Jury Trial) and 8.16 (Submission to
Jurisdiction) of the BCA are incorporated herein by reference and shall apply to this Agreement, mutatis mutandis.

 

[remainder
of page intentionally left blank; signature page follows]

 

    6

     

    

 

IN
WITNESS WHEREOF, each of the Parties has caused this Transaction Support Agreement to be duly executed on its behalf as of the day
and year first above written.

 

	 	

    MINORITY
    EQUALITY OPPORTUNITIES ACQUISITION INC. 

	 	 	 
	 	By:	 
	 	Name:	Shawn
D. Rochester
	 	Title:	President
& CEO

 

[MEOA
Signature Page to Transaction Support Agreement]

 

    7

     

    

  

	 	 
	 	Name
    of Stockholder

 

[Stockholder
Signature Page to Transaction Support Agreement]

 

    8

     

    

 

Schedule
A

 

Owned
Equity Securities

 

	Security	 	Number
	[●]	 	[●]

 

 

 9Document

EXHIBIT 10.4

AMENDMENT NO. 1 TO THE INTELLECTUAL PROPERTY LICENSE AGREEMENT

This AMENDMENT NO. 1 TO THE INTELLECTUAL PROPERTY LICENSE
AGREEMENT (this “Amendment No. 1”), dated as of June 17, 2022 (the “Amendment Date”), is entered into by and among Avon Products, Inc., a New York corporation, Avon International Operations, Inc., a Delaware corporation, Avon NA IP LLC, a Delaware limited liability company, and The Avon Company (f/k/a New Avon LLC, f/k/a C-A NA LLC), a Delaware limited liability company.

RECITALS

WHEREAS, the Parties have heretofore entered into that certain Intellectual Property License Agreement dated as of March 1, 2016 (the “Agreement”);

WHEREAS, the Parties wish to amend the Agreement to reflect the terms and conditions set forth herein; and

WHEREAS, Section 11.08 of the Agreement provides that the Agreement may be amended if, and only if, such amendment is in writing and is signed by the Party against whom such amendment shall be enforced.

NOW, THEREFORE, in consideration of the mutual agreements set forth herein, the Parties, intending to be bound, hereby agree as follows:

1.Definitions. Any capitalized term that is used herein but is not otherwise defined in this Amendment No. 1 shall have the meaning given to such term in the Agreement.

      2. Amendments.

(a) Section 2.03(a) of the Agreement is hereby amended and restated in
its entirety as follows:

“Subject to this Section 2.03, each Licensee may grant sublicenses under the Licensed IP Rights to its Affiliates or to third parties; provided that such Licensees may not grant any such sublicense to any Restricted Person. Any sublicense to a Subsidiary shall automatically terminate if the sublicensee ceases to be a Subsidiary of Licensee.”

             (b) Section 3.04(a) of the Agreement is hereby amended and restated in
its entirety as follows:

“Each Licensee agrees that in connection with all uses by such Licensee or permitted sublicensees of the Trademarks or Trademark Extensions included in the Licensed IP Rights, and all products and services offered in connection therewith, such Licensee and any permitted sublicensee: (i) shall not make any statements that are misleading as to the quality of the products or services, or that cause confusion with the business or identity of a Person (provided that the use by Licensee and its permitted sublicensees of the Trademarks or Trademark Extensions included in the Licensed IP Rights within the scope of the licenses granted pursuant to this Agreement shall not be deemed to cause confusion as to the business or identity of any Person),

EXHIBIT 10.4

(ii) shall be in compliance with all Judgments, (iii) shall not enter into any agreement that conflicts with, results in any breach of, or constitutes a default under, the terms and conditions of this Agreement, (iv) shall not do, omit to do, or permit to be done, any act that will invalidate any registration of any Trademark, Trademark Extension or other associated IP Rights included in the Licensed IP Rights, (v) shall not do any act that will cause substantial damage to a Specified Quality Brand, provided (A) no Licensee nor any sublicensee shall be deemed to have caused substantial damage to a Specified Quality Brand by exercising its rights under this Agreement, (B) the occurrence of an ordinary adverse event in the conduct of any such Licensee’s or sublicensee’s business or an act outside the reasonable control of such Licensee or sublicensee cannot be the basis for an allegation of substantial damage under this Section 3.04, (C) upon learning of any act that will cause substantial damage to a Specified Quality Brand, Licensor shall promptly give notice to the applicable Licensee or sublicensee, (D) such Licensee or sublicensee shall have a reasonable period of time to remedy such act before Licensor seeks to enforce any rights under this Agreement in connection with the act that violates Section 3.04 but without limiting Licensor’s rights to enforce under this Agreement should that same act violate another section of this Agreement, and (E) the burden to prove substantial damage to a Specified Quality Brand under this Section 3.04 is on the Licensor and must be met by clear and convincing evidence, (vi) shall not file applications to register any Trademarks or design patent registrations that consist in whole or in part of, or are confusingly similar to, the Trademarks or Trademark Extensions included in the Licensed IP Rights, or assist any Person in doing the same, and (vii) shall not contest, challenge, or otherwise take any action adverse to Licensor’s ownership of or rights in and to the Trademarks or Trademark Extensions included in the Licensed IP Rights, or assist any Person in doing the same. Notwithstanding anything to the contrary herein, in the event that any Licensee or sublicensee engages in, or conducts, any animal testing with respect to any products or services offered under any Specified Quality Brand, such Licensee or sublicensee, as applicable, shall be deemed to have caused substantial damage to such Specified Quality Brand.”

            (c)Article VI of the Agreement is hereby amended by adding the following language as new Section 6.02 of the Agreement:

“SECTION 6.02.        Right of First Offer. In the event that, during the Term, Avon NA or any of its Affiliates intends, desires or proposes to transfer, assign, sublicense, pledge, create an encumbrance or lien on or otherwise monetize in any manner its rights under any NA Licensed IP Rights (excluding any sublicenses of such NA Licensed IP Rights to Avon NA’s Subcontractors) (such rights, collectively, the “ROFO Rights” and any such transaction, a “ROFO-Triggering Transaction”), whether such intent, desire or proposal is independent on the part of Avon NA or related to or arising from receipt by Avon NA of an unsolicited offer to do so, Avon NA shall, and shall cause its Affiliates to, provide written notice (an “Offer Notice”) to Avon International that Avon NA intends, desires or proposes to engage in a ROFO-Triggering Transaction (it being understood that (a) such Offer Notice shall set forth all material terms that Avon NA would seek in the event that the rights afforded to Avon International under this Section 6.02 were exercised by Avon International and Avon NA would enter into the ROFO-Triggering Transaction with Avon International (which terms sought by Avon NA and described in such Offer Notice shall be made in good faith and shall not be made with the purpose of frustrating or otherwise circumventing Avon International’s rights under this Section 6.02), and (b) in the event the Offer Notice is provided as a result of Avon NA receiving an unsolicited offer to engage in a ROFO- Triggering Transaction, such Offer Notice shall set forth all material terms of such offer). The provision of an Offer Notice shall constitute an offer (the “Offer”) by Avon NA to provide Avon

EXHIBIT 10.4

International such ROFO Rights and engage in the ROFO-Triggering Transaction with Avon International on the terms set forth in such Offer Notice. Avon International shall have a thirty
(30) day period commencing on the date the Offer is received by Avon International (the “Offer Period”) in which to accept such Offer and, during the Offer Period (and, during the sixty (60)- period described in the following sentences of this Section 6.02, if applicable), Avon NA shall, and shall cause its Affiliates to, (i) reasonably cooperate with Avon International, and reasonably respond to Avon International, with respect to any information reasonably requested by Avon International in order to evaluate the ROFO-Triggering Transaction and (ii) not engage in any manner with respect to or be a party to any ROFO-Triggering Transaction with any Person other than Avon International (including by not making available to any such Person any confidential information with respect to the ROFO Rights). At the same time, Avon International shall, during the Offer Period, use commercially reasonable efforts to evaluate and respond to the Offer in an expeditious manner. In the event that Avon International provides a notice of acceptance of the Offer to Avon NA prior to the expiration of such Offer Period, the Parties shall negotiate in good faith the terms of definitive agreements which shall reasonably reflect the material terms of the Offer. If Avon International fails to notify Avon NA of its acceptance of such Offer prior to the expiration of the Offer Period, or if Avon International accepts the Offer during the Offer Period but the Parties do not agree on and enter into definitive agreements within sixty (60) days following the date of Avon International’s notice of acceptance (other than as a result of Avon NA’s breach of this Agreement or otherwise acting in bad faith), Avon International shall be deemed to have declined such Offer, in which case Avon NA shall have the right to negotiate and enter into definitive agreements with respect to such ROFO-Triggering Transaction with any third party on identical or more favorable, in the aggregate, as to Avon NA, terms and conditions as were set forth in the Offer Notice. For the avoidance of doubt, Avon NA and Avon International shall comply in all respects with the procedures set forth in this Section 6.02 with respect to any newly proposed ROFO-Triggering Transaction.”

(d) Section 9.02 of the Agreement is hereby amended and restated in its
entirety as follows:

“SECTION 9.02 Indemnity by Avon NA. Avon NA shall indemnify and hold harmless Avon International, its Affiliates, equity holders, and each of their Personnel (collectively, “Avon International Indemnified Parties”) and defend such Avon International Indemnified Party, from and against all Losses arising out of or resulting from Claims by any third Person against such Avon International Indemnified Party arising out of (a) any material breach by Avon NA of any of its representations or warranties set forth in this Article IX or of the covenants set forth in Section 6.01 or (b) the conduct or operation by Avon NA of any Restricted Business (all such Claims, together with all Claims that are the subject of the indemnity by Avon NA in Section 2.08(c), hereafter referred to as “Avon International Indemnified Claims”).”

(e) Section 9.03 of the Agreement is hereby amended and restated in its
entirety as follows:

“SECTION 9.03 Indemnity by Avon International. Avon International shall indemnify and hold harmless Avon NA, its Affiliates and each of their Personnel (collectively, “Avon NA Indemnified Parties”) and defend such Avon NA Indemnified Party, from and against all Losses arising out of or resulting from Claims by any third Person against such Avon NA

EXHIBIT 10.4

Indemnified Party arising out of (a) any material breach by Avon International of any of its representations or warranties set forth in this Article IX or of the covenants set forth in Section 6.01, (b) Avon International’s exercise of the licenses granted under this Agreement to Avon International, (c) the conduct or operation by Avon International of any Restricted Business, or
(d) the operation by Avon International of the Avon International Business from and after the Effective Date, including any product liability Claims or Claims for infringement or misappropriation of any IP Rights (all such Claims, together with all Claims that are the subject of the indemnity by Avon International in Section 2.08(d), hereafter referred to as “Avon NA Indemnified Claims”).”

(f) Schedule F of the Agreement is hereby amended by removing “Natura Cosmeticos S.A.” and replacing it with “O Boticário”.

      3. Notices. All notices sent under this Amendment No. 1 shall be treated as notices for the purposes of Section 11.05 of the Agreement and may be delivered as specified therein. The addresses to which notices from Avon NA to Avon International shall be sent are hereby amended as follows:

If from Avon NA to Avon International:

Avon Products, Inc. One Avon Place Suffern, NY 10901
Attention: General Counsel Email: ginny.edwards@avon.com
with a copy to (which copy alone shall not constitute notice): Avon Products, Inc.
Nunn Mills Road
Northampton NN1 5PA United Kingdom
Attention: Legal Department

     4. Conflicts. In the event of any conflict between the terms and conditions of this Amendment No. 1, on the one hand, and the Agreement (other than this Amendment No. 1), on the other hand, the terms and conditions of this Amendment No. 1 shall govern solely to the extent of any such conflict.

    5. Governing Law. This Amendment No. 1 shall be governed by, and construed in accordance with, the internal laws of the State of New York applicable to agreements made and to be performed entirely within such state, without regard to the conflicts of law principles of such state.

  6. Counterparts; Effectiveness; Third Party Beneficiaries. This Amendment No. 1 may be executed in two or more identical counterparts (including by facsimile or electronic transmission), each of which shall be an original, with the same effect as if the signatures thereto

and hereto were upon the same instrument, and shall become effective as of the Amendment Date when one or more counterparts have been signed by each Party and delivered (by facsimile, electronic transmission or otherwise) to the other Parties. Except as expressly set forth in the Agreement, this Amendment No. 1 is for the sole benefit of the Parties and their permitted assigns and nothing expressed or referred to in this Amendment No. 1 will be construed to give any Person, other than the Parties and such permitted assigns, any legal or equitable right, 

EXHIBIT 10.4

remedy or claim under or with respect to this Amendment No. 1 or any provision of this Amendment No. 1, whether as third-party beneficiary or otherwise.

  7. Amendments and Waivers. This Amendment No. 1 may be amended or waived if, and only if, such amendment or waiver is in writing and signed by the Party against whom such amendment or waiver shall be enforced. The failure of any Party to exercise any right, power or remedy provided under this Agreement or otherwise available in respect hereof at law or in equity, or to insist upon compliance by any other Party with its obligations hereunder, shall not constitute a waiver by such Party of its right to exercise any such other right, power or remedy or to demand such compliance.

 8. Agreement Otherwise Unchanged. This Amendment No. 1 is limited precisely as written and shall not be deemed to be an amendment to, or waiver of, any other term or condition of the Agreement. Wherever the Agreement is referred to therein, such reference shall be to the Agreement as amended hereby. Except as expressly amended by this Amendment No. 1, all terms and conditions of the Agreement shall remain unchanged and in full force and effect.

 9. Section Headings. The section headings used herein are for reference and convenience only, and shall not enter into the interpretation hereof.

 10. Severability. If any term or other provision of this Amendment No. 1 is or becomes invalid, illegal or incapable of being enforced because of any Applicable Law or public policy, all other conditions and provisions of this Amendment No. 1 shall nevertheless remain in full force and effect so long as the economic or legal substance of this Amendment No. 1 is not affected in any manner materially adverse to any Party. Upon such determination that any term or other provision is invalid, illegal or incapable of being enforced, the Parties shall negotiate in good faith to modify this Amendment No. 1 so as to effect the original intent of the Parties as closely as possible in a mutually acceptable manner in order that this Amendment No. 1 be given the effect originally contemplated to the greatest extent possible.

[Signature Page Follows]

EXHIBIT 10.4

IN WITNESS WHEREOF, the Parties have caused this Amendment No. 1 to be duly executed by their respective authorized officers as of the Amendment Date.

AVON PRODUCTS, INC.

By: 
Name: Ginny Edwards
Title:   VP, General Counsel & Corporate Secretary

AVON INTERNATIONAL OPERATIONS, INC.

By: 
Name: Ginny Edwards Title: Director & Secretary

AVON NA IP LLC

By: 
Name: Ginny Edwards Title: Manager

EXHIBIT 10.4

Signature Page to Amendment No. 1 to the Intellectual Property License Agreement

IN WITNESS WHEREOF, the Parties have caused this Amendment No. 1 to be duly executed by their respective authorized officers as of the Amendment Date.

THE AVON COMPANY

						
		
		

                                        

Suk Cha
CEO & Chairman

Signature Page to Amendment No. 1 to the Intellectual Property License Agreement

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00350-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00350-of-00352.parquet"}]]